Literature DB >> 27067054

Dynamics of Protein Expression Reveals Primary Targets and Secondary Messengers of Estrogen Receptor Alpha Signaling in MCF-7 Breast Cancer Cells.

Andrei P Drabovich1, Maria P Pavlou2, Christina Schiza2, Eleftherios P Diamandis3.   

Abstract

Estrogen receptor alpha (ERα)-mediated proliferation of breast cancer cells is facilitated through expression of multiple primary target genes, products of which induce a secondary response to stimulation. To differentiate between the primary and secondary target proteins of ERα signaling, we measured dynamics of protein expression induced by 17β-estradiol in MCF-7 breast cancer cells. Measurement of the global proteomic effects of estradiol by stable isotope labeling by amino acids in cell culture (SILAC) resulted in identification of 103 estrogen-regulated proteins, with only 40 of the corresponding genes having estrogen response elements. Selected reaction monitoring (SRM) assays were used to validate the differential expression of 19 proteins and measure the dynamics of their expression within 72 h after estradiol stimulation, and in the absence or presence of 4-hydroxytamoxifen, to confirm ERα-mediated signaling. Dynamics of protein expression unambiguously revealed early and delayed response proteins and well correlated with presence or absence of estrogen response elements in the corresponding genes. Finally, we quantified dynamics of protein expression in a rarely studied network of transcription factors with a negative feedback loop (ERα-EGR3-NAB2). Because NAB2 protein is a repressor of EGR3-induced transcription, siRNA-mediated silencing of NAB2 resulted in the enhanced expression of the EGR3-induced protein ITGA2. To conclude, we provided a high-quality proteomic resource to supplement genomic and transcriptomic studies of ERα signaling.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27067054      PMCID: PMC5083091          DOI: 10.1074/mcp.M115.057257

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  58 in total

1.  Genome-wide identification of high-affinity estrogen response elements in human and mouse.

Authors:  Véronique Bourdeau; Julie Deschênes; Raphaël Métivier; Yoshihiko Nagai; Denis Nguyen; Nancy Bretschneider; Frank Gannon; John H White; Sylvie Mader
Journal:  Mol Endocrinol       Date:  2004-03-04

2.  EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin.

Authors:  Joerg Kumbrink; Kathrin H Kirsch; Judith P Johnson
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

3.  Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer.

Authors:  Reto Stricker; Raphael Eberhart; Marie-Christine Chevailler; Frank A Quinn; Paul Bischof; René Stricker
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

4.  Genome-wide analysis of estrogen receptor binding sites.

Authors:  Jason S Carroll; Clifford A Meyer; Jun Song; Wei Li; Timothy R Geistlinger; Jérôme Eeckhoute; Alexander S Brodsky; Erika Krasnickas Keeton; Kirsten C Fertuck; Giles F Hall; Qianben Wang; Stefan Bekiranov; Victor Sementchenko; Edward A Fox; Pamela A Silver; Thomas R Gingeras; X Shirley Liu; Myles Brown
Journal:  Nat Genet       Date:  2006-10-01       Impact factor: 38.330

5.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

6.  Estrogen receptor regulates E2F1 expression to mediate tamoxifen resistance.

Authors:  Maggie C Louie; Ashley McClellan; Christina Siewit; Lauren Kawabata
Journal:  Mol Cancer Res       Date:  2010-03-09       Impact factor: 5.852

7.  Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma.

Authors:  S A Abdulkadir; J M Carbone; C K Naughton; P A Humphrey; W J Catalona; J Milbrandt
Journal:  Hum Pathol       Date:  2001-09       Impact factor: 3.466

8.  Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells.

Authors:  A Inoue; Y Omoto; Y Yamaguchi; R Kiyama; S-I Hayashi
Journal:  J Mol Endocrinol       Date:  2004-06       Impact factor: 5.098

9.  Optimization of estrogen growth response in MCF-7 cells.

Authors:  T E Wiese; L G Kral; K E Dennis; W B Butler; S C Brooks
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

10.  The transcriptional corepressor NAB2 inhibits NGF-induced differentiation of PC12 cells.

Authors:  Z Qu; L A Wolfraim; J Svaren; M U Ehrengruber; N Davidson; J Milbrandt
Journal:  J Cell Biol       Date:  1998-08-24       Impact factor: 10.539

View more
  12 in total

1.  Discovery of a Human Testis-specific Protein Complex TEX101-DPEP3 and Selection of Its Disrupting Antibodies.

Authors:  Christina Schiza; Dimitrios Korbakis; Efstratia Panteleli; Keith Jarvi; Andrei P Drabovich; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2018-08-10       Impact factor: 5.911

2.  Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer Cells.

Authors:  Twishi Gulati; Cheng Huang; Franco Caramia; Dinesh Raghu; Piotr J Paul; Robert J A Goode; Simon P Keam; Scott G Williams; Sue Haupt; Oded Kleifeld; Ralf B Schittenhelm; Cristina Gamell; Ygal Haupt
Journal:  Mol Cell Proteomics       Date:  2018-02-20       Impact factor: 5.911

3.  Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients.

Authors:  Andrei P Drabovich; Punit Saraon; Mikalai Drabovich; Theano D Karakosta; Apostolos Dimitromanolakis; M Eric Hyndman; Keith Jarvi; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2019-06-27       Impact factor: 5.911

4.  A novel long non-coding RNA regulates the integrin, ITGA2 in breast cancer.

Authors:  Adele F Holloway; Joanne L Dickinson; Tristan Joseph Verhoeff
Journal:  Breast Cancer Res Treat       Date:  2022-01-31       Impact factor: 4.872

Review 5.  Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.

Authors:  Nathan P Manes; Aleksandra Nita-Lazar
Journal:  J Proteomics       Date:  2018-02-13       Impact factor: 4.044

6.  Quantification of Human Kallikrein-Related Peptidases in Biological Fluids by Multiplatform Targeted Mass Spectrometry Assays.

Authors:  Theano D Karakosta; Antoninus Soosaipillai; Eleftherios P Diamandis; Ihor Batruch; Andrei P Drabovich
Journal:  Mol Cell Proteomics       Date:  2016-07-01       Impact factor: 5.911

7.  Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility.

Authors:  Dimitrios Korbakis; Christina Schiza; Davor Brinc; Antoninus Soosaipillai; Theano D Karakosta; Christine Légaré; Robert Sullivan; Brendan Mullen; Keith Jarvi; Eleftherios P Diamandis; Andrei P Drabovich
Journal:  BMC Med       Date:  2017-03-23       Impact factor: 8.775

8.  Identification of TEX101-associated Proteins Through Proteomic Measurement of Human Spermatozoa Homozygous for the Missense Variant rs35033974.

Authors:  Christina Schiza; Dimitrios Korbakis; Keith Jarvi; Eleftherios P Diamandis; Andrei P Drabovich
Journal:  Mol Cell Proteomics       Date:  2018-11-14       Impact factor: 5.911

9.  Moonlighting Proteins and Cardiopathy in the Spatial Response of MCF-7 Breast Cancer Cells to Tamoxifen.

Authors:  Abdulrab Ahmed M Alkhanjaf; Roberto Raggiaschi; Mark Crawford; Gabriella Pinto; Jasminka Godovac-Zimmermann
Journal:  Proteomics Clin Appl       Date:  2019-07-25       Impact factor: 3.494

Review 10.  Small Heat Shock Proteins in Cancers: Functions and Therapeutic Potential for Cancer Therapy.

Authors:  Jixian Xiong; Yuting Li; Xiangyu Tan; Li Fu
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.